Home| Journals | About Us|Contact Us|www.statperson.com

• Thesis to Book with ISBN
• Thesis Writer
• Subscription
• Article in Press
• Editorial Board
• Current Issue
• Publication Charges
• Archives
• Authors Information
• Contact Us
• Indexing

[Abstract] [PDF] [HTML] [Linked References]

MedPulse - International Medical Journal, ISSN 2348-2516 E-ISSN: 2348-1897

Volume 1, Issue 6, June 2014 pp 324-327

Research Article

Incidence of lipoprotein lipase D9N mutation and its association with risk of CAD and dyslipidemia in Indians

Mallakmir S M¹, Kane G R¹, Nadkarni J², Vidhate D A³, Deshpande S¹, Mallakmir S S⁴,Parundekar A², Ibrahim R²

¹Department of Cardiology, ²Department of Biochemistry, ⁴Clinical Geneticist, Dr. D.Y. Patil Medical College, Hospital and Research center, Nerul, Navi Mumbai. Maharashtra, INDIA.

³Department of Biotechnology and Bioinformatics, Dr. D.Y. Patil University, CBD Belapur, Navi Mumbai. Maharashtra, INDIA.

Linked References

1. Joshi PP. Why is coronary heart disease increasing in Indians? Cardiovascular risk factors in the Indian scenario. South Asian J Prev Cardiol 2003; 7:4.
2. Wittrup HH, Tybjaerg-Hansen A and Nordestgaard BG: Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 99:2901–2907. 1999.
3. Mallakmir SM, Kane G R, Mallakmir SS, Vidhate DA et al. A study of Apo lipoprotein E polymorphism and lipid profile in coronary artery disease. International Journal of Recent Trends in Science and Technology; 2014; 11: 2; 234-237.

4. Vidhate D A, Thomas J, Gupte A M. Association of IL-6 with Diabetes Mellitus in Indian Population from Navi Mumbai. International Journal of Recent Trends in Science and Technology 2013; 8:2; 100-102.

5. Vidhate DA, Thomas J, and Gupte A M. IL-6: An important mediator of obesity based inflammation. International Journal of Advanced and Innovative Research 2013; 2: 9; 283-286.

6. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens 2004; 18: 73-8.
7. Mohan V, Deepa R, Rani SS, Premalatha G; Chennai Urban Population Study (CUPS No.5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001;38:682-7.
8. Goenka S, Prabhakaran D, Ajay VS, Reddy KS. Preventing cardiovascular disease in India translating evidence to action. Curr Sci 2009; 97: 3.
9. GuanYu-Ming, Gui Yong-Hao, Luo Fei-Hong et al. Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity[J]. CJCP, 2010, 12(3): 161-164.
10. Mead JR, Irvine SA, Ramji DP (December 2002). "Lipoprotein lipase: structure, function, regulation, and role in disease". J. Mol. Med. 80 (12): 753–69.
11. Kuo P.T. Dyslipidemia and Coronary Artery Disease  Clin. Cardiol.; 1994; 17:5 19-527.
12. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J CardiovascRisk. 1996;3:213–219.
13. Wang, H., and M. C. Schotz. 2002. The lipase gene family. J. Lipid Res. 43: 993–999.
14. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The metabolic and molecular bases of inherited disease. Vol. 2. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1913–1932.
15. Cyril James. Risk Factors for Coronary Artery Diseases: A Study Among Patients With Ischemic Heart Disease in Kerala; 2013;1:1; 7-11.
16. Fisher RM, Humphries SE and Talmud PJ: Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis. 135:145–159. 1997.
17. Souverein OW, Jukema JW, Boekholdt SM, Zwinderman A and Tanck M. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. European Journal of Human Genetics (2005) 13, 445–451.
18. Barter PJ, Rye K-A. High density lipoproteins and coronary heart disease.Atherosclerosis. 1996;121:1–12.
19. Nordestgaard BG, Wootton R, Lewis B. Selective retention of VLDL,IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbitsin vivo: molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol. 1995;15:534 –542.